| Literature DB >> 28271064 |
Abstract
Since 2007, ligation of the intersphincteric fistula tract (LIFT) for the management of anal fistula was all introduced with initial success and excitement. It remains controversial which surgical procedure is suitable for transsphincteric fistula, especially to complex anal fistula. This retrospective study was designed to evaluate the results in patients with recurrent anal fistula by LIFT. A retrospective study of 55 complex fistula patients who underwent LIFT procedure in a single medical center was analyzed. Patients and fistula characteristics, complications, and recurrences were reviewed. All 55 patients underwent the procedure with a median follow-up of 16 months. Median operative time was 44 (range 23-88) minutes. Of the 55 patients, 33 (60%) healed completely and did not require any further surgical treatment at end of follow-up. Twenty-two (40%) recurrences and six complications were observed. Compared with patients who had undergone more than two surgical procedures, LIFT was more suitable for patients who had undergone one to two surgical procedures, and significant difference was observed in number of operations before LIFT (p = 0.002). Clinicians can consider the use of LIFT for the treatment of recurrent anal fistulas. A larger number of patients and prospective study are needed to be performed.Entities:
Mesh:
Year: 2017 PMID: 28271064 PMCID: PMC5320375 DOI: 10.1155/2017/3152424
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Continence Grading Scale of preoperation.
| Type of incontinence | Never | Rarely | Sometimes | Usually | Always |
|---|---|---|---|---|---|
| Gas | 48 | 0 | 4 | 2 | 1 |
| Liquid | 50 | 1 | 3 | 1 | 0 |
| Solid | 55 | 0 | 0 | 0 | 0 |
| Wears pad | 53 | 0 | 0 | 2 | 0 |
| Lifestyle alteration | 51 | 0 | 2 | 2 | 0 |
0 = perfect. 20 = complete incontinence. Never = 0 (never). Rarely = 1/month. Usually = 1/week. Always = ≥1/day. The continence score is determined by adding points from the above table, which takes into account the type and frequency of incontinence and the extent to which it alters the patient's life.
Demographic and clinical data.
| Total number of patients | 55 |
|
| |
| Sex (male/female) | 33/20 |
| Median age, y (range) | 46 (17–62) |
| Comorbidities ( | 18 |
| Diabetes mellitus | 4 |
| Crohn's disease | 6 |
| Tuberculosis | 3 |
| Hypertension | 4 |
| Surgical procedures per patient before LIFT | 2.4 |
| Fistula type | |
| Transsphincteric fistula | 31 (6 horseshoe fistulas) |
| Intersphincteric fistula | 20 (10 horseshoe fistulas) |
| Rectovaginal fistula | 4 |
Outcomes of LIFT procedure.
| Operation time, median (range) | 44 (23–88) minutes |
|
| |
| Follow-up period, median | 16 months |
|
| |
| Median time of healing time, median (range) | 4 (2–15) months |
|
| |
| Healing rate | 60% (33/55) |
|
| |
| Recurrence rate | 40% (22/55) |
|
| |
| Postoperative complications | Anal fissure (1) |
| Persistent pain (2) | |
| Wound infection (1) | |
| Fecal incontinence (1) | |
| Gas incontinence (1) | |
|
| |
| Number of recurrence | Horseshoe fistula (10) |
| Transsphincteric fistula (8) | |
| Intersphincteric fistula (3) | |
| Rectovaginal fistula (1) | |
|
| |
| Length of stay | 2 (1–4) day |
Relationship of previous operations with LIFT success.
| Number of operations | Success | Recurrence |
|
|---|---|---|---|
| 1-2 | 25 | 7 | |
| >2 | 8 | 15 | |
|
| |||
| Total | 33 | 22 | 0.002 |
Worldwide experience with LIFT.
| First author |
| Healing | Recurrence | Follow-up |
|---|---|---|---|---|
| Rojanasakul | 18 | 94.40% | — | — |
| Shanwani | 45 | 82.20% | 17.70% | 9 (2–16) months |
| Bleier | 29 | 57% | 10.30% | 20 (0–58) weeks |
| Ellis | 31 | 94% | — | 15 (12–30) months |
| Ooi | 25 | 68% | 28% | 22 (3–43) weeks |
| Aboulian | 25 | 68% | 12% | 27 (8–158) weeks |
| Sileri | 18 | 83% | NA | 6 (4–10) months |
| Tan | 93 | 86% | 6.50% | 6 (1–85) weeks |
| Mushaya | 25 | 68% | 8% | 16.4 (8.4–31.3) months |
| Han | 21 | 95% | — | 14 (12–15) months |
| Lo | 25 | 89% | 0 | 9.8 (1–21.5) months |
| Wallin | 93 | 40% | 26% | 19 (44–55) months |
| van Onkelen | 41 | 51% | — | 15 (7–21) months |
| Abcarian | 40 | 74% | 8% | 18 (2–64) weeks |
| van Onkelen | 22 | 82% | — | 19.5 (3–35) months |
| Lehmann | 17 | 65% | — | 13.5 (8–26) months |
| Sirikurnpiboon | 41 | 83% | 19% | 18 weeks |
| Tan | 16 | 68.80% | — | 26 (12–51) months |
| Liu | 38 | 61% | — | 26 (3–44) months |
| Gingold | 15 | 67% | 58% | 11.2 (3–15) months |
| Romaniszyn | 14 | 57% | 7.10% | 8 (7–17) months |
| Dalbem | 22 | 77.00% | 23% | 14 (4–24) months |
| Tomiyoshi | 8 | 88% | — | 2–6 weeks |
| Baharudin | 56 | 71% | 5.35% | 20.98 (2.9–151.74) weeks |
| Ye | 43 | 87% | 12.80% | 15 (12–24) months |
| Schulze | 75 | 88% | 12% | 14.6 ± 1.7 months |
| Parthasarathi | 167 | 94.10% | 5.90% | 12 (4–22) months |